U.S. and European pharmaceutical industry organizations on Wednesday urged governments not to extend the delays prescribed by COVID-19 vaccine developers between the first and second shot, as the U.K. has begun to do to deal with current bottlenecks or shortages.The outlook: The U.K. decision, triggered by the severity of the COVID-19 pandemic spike and the ambitious vaccination campaign the government has set, is now coming under fire from the pharmaceuticals industry.
The industry reaction is also a way of warning governments that vaccine developers cannot be held responsible in the future for incidents or adverse side effects during vaccination campaigns that would not have followed strictly the recommended doses and schedules.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: